发明名称 |
Treatment of leukemia with histone deacetylase inhibitors |
摘要 |
Provided herein are combinations comprising an HDAC inhibitor and azacitidine for the treatment of leukemia in a subject in need thereof. Provided herein are combinations comprising an HDAC inhibitor and azacitidine for the treatment of acute myelogenous leukemia in a subject in need thereof. Also provided herein are methods for treating leukemia in a subject in need thereof, comprising administering to the subject an effective amount of the above combination or an HDAC inhibitor, as well as methods for treating acute myelogenous leukemia in a subject in need thereof, comprising administering to the subject an effective amount of the above combination or an HDAC inhibitor. |
申请公布号 |
AU2015288060(A1) |
申请公布日期 |
2017.02.09 |
申请号 |
AU20150288060 |
申请日期 |
2015.07.06 |
申请人 |
Tamang, David;Acetylon Pharmaceuticals, Inc. |
发明人 |
Tamang, David Lee;Jones, Simon S.;Min, Chengyin;Yang, Min |
分类号 |
A61K31/4184;A61K31/706;A61P35/02 |
主分类号 |
A61K31/4184 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|